Psychiatry and Neurology, Neurology · Indianapolis, IN
NPI
1235133802
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1400 N Ritter Ave Ste 220
Indianapolis, IN, 46219
Phone (317) 715-5600
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
241 services
Medicare patients, 2024
154
Average age 68
Drug cost, 2024
$1.1M
2,101 prescriptions
Company payments, 2025
$3,254
From 39 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raymond J Loffer was code 99214 (office e&m - established), 150 times for 98 patients. In total Raymond J Loffer billed 241 services in 11 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 150 | 98 | $86.00 | $13K |
| 99223 Hospital E&M - Initial | Facility | 25 | 25 | $122.64 | $3,066 |
| 99232 Hospital E&M - Subsequent | Facility | 17 | 13 | $58.30 | $991 |
| 99215 Office E&M - Established | Office | 14 | 14 | $116.79 | $1,635 |
By year: 2022 $38K for 385 services; 2023 $23K for 262 services; 2024 $22K for 241 services.
Medicare prescription drug claims, 2024
In 2024, the drug Raymond J Loffer prescribed most often to Medicare patients was Gabapentin, with 495 prescriptions and refills. In total Raymond J Loffer wrote 2,101 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 495 | 1,050 | 154 | $14K |
| Ropinirole Hcl Generic | 214 | 459 | 54 | $4,516 |
| Topiramate Generic | 117 | 240 | 25 | $2,206 |
| Clonazepam Generic | 106 | 136 | 22 | $885 |
| Lamotrigine Generic | 90 | 170 | 18 | $1,497 |
| Levetiracetam Generic | 83 | 161 | 16 | $1,960 |
| Fluticasone Propionate Generic | 59 | 108 | 20 | $375 |
| Modafinil Generic | 55 | 87 | 13 | $18K |
| Pregabalin Generic | 51 | 97 | 13 | $3,761 |
| Xywav Sodium,calcium,mag,pot Oxybate | 41 | 41 | Under 11 | $806K |
| Armodafinil Generic | 41 | 59 | Under 11 | $4,167 |
| Pantoprazole Sodium Generic | 40 | 44 | Under 11 | $581 |
| Memantine Hcl Generic | 38 | 56 | Under 11 | $901 |
| Lacosamide Generic | 38 | 52 | Under 11 | $3,971 |
| Clopidogrel Clopidogrel Bisulfate | 36 | 103 | 13 | $209 |
Brand drugs: 135 claims; generic drugs: 1,966 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raymond J Loffer $3,254 ($3,254 in general payments such as food, travel and fees) from 39 companies. The largest payer was Abbvie Inc. with $524.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 30 | $524 |
| Pfizer Inc. PFE | 11 | $220 |
| UCB, Inc. UCB.BR | 6 | $206 |
| Catalyst Pharmaceuticals, Inc. CPRX | 5 | $184 |
| Biogen, Inc. BIIB | 7 | $178 |
| SK Life Science, Inc. | 4 | $113 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $111 |
| Vanda Pharmaceuticals Inc. VNDA | 4 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $93.03 |
| Argenx US, Inc. ARGX | 5 | $92.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.